The Fairway Group (FWM) is set to report earnings after the bell on May 26th, 2015. Immediately before the last earnings report, the stock made a nice run up and continued to run to over $7, before being re shorted…
Archived Articles
Video Chart Reviews For Mon March 9 + KYTH and ZGNX Trade Strategies
Video Chart Reviews For Mon March 9 + KYTH and ZGNX Trade Strategies.. Video Chart Reviews For Mon March 9 + KYTH and ZGNX Trade Strategies…Video Chart Reviews For Mon March 9 + KYTH and ZGNX Trade Strategies..Video Chart Reviews For…
AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential
The advent of The Affordable Care Act (Obamacare) is on the horizon as the healthcare sector of the market continues its strong rally. With new Food and Drug Administration (FDA) regulatory easing, congressional bills, and The Obama Administration directive in…
Updated: (cleaned up) Market Historical Chart For Review: Economic Commentary and Market Forecast Opinion.
Above, we can see an historical chart of The Dow going back to 2003. Take note of the current market trend and compare to past trends. I feel the market needs a correction and is over extended on the QE…
AVEO Pharma’s Tivozanib Likely To Be Approved
With the current record market run, small cap biopharmas have kept pace and continue to trend higher, being one of the best sectors for both trading and investing over the past year. With 39 new drugs approved, 2012 showed the…
$AVEO Due Diligence: Catalyst: Adcomm May 2nd
2 days ago, I issued a bullish chart alert for $Aveo. Some basic DD on Aveo: First off, one of the best articles covering Aveo’s tivozanib, which is designed as a front line treatment for metastatic renal cell carcinoma (RCC)…
Antares Pharma ($ATRS) Technical Long Trade Thesis and Chart
Antares Pharma (ATRS) is being set up to run to at least $3.85, Thesis follows below; The chart above shows “quiet” accumulation. The purple line is the accumulation, notice for the first time, the accumulation points up, MACD and RSI…
Aveo Chart Technicals
I see a strong chart set up from above. We see a nice continuation pattern, super strong accumulation and RSI, both showing a cup and handle type pattern.Therefore, my short term trade target opinion is $8.25 Aveo has an…
Valeant Acquires Obagi, Which Biotechs Are Next?
Yesterday, Obagi Medical Products (OMPI) was acquired by Valeant Pharmaceuticals (VRX) for $19.75 a share in an all cash deal. Last summer I covered in depth, acquisition rumors regarding Obagi. At the time, good private sources of mine confirmed that…
Significant catalysts and an unfortunate PR mistake present an opportunity in AcelRx Pharmaceuticals.
With The positive result of the first phase III study, coupled with the positive responses of nurses and patients, AcelRx Pharmaceuticals (ACRX) saw a substantial increase in its share price, reaching a high of $5.19 in late November. As is often…
